The ongoing COVID-19 pandemic has resulted in millions of deaths globally, highlighting
the need to develop potent prophylactic and therapeutic strategies against SARS-CoV-2 …

The exploration of non-toxic and cost-effective dietary components, such as epigallocatechin
3-gallate and myricetin, for health improvement and disease treatment has recently attracted …

Introduction: The SARS-CoV-2 outbreak has threatened the human population globally as
the numbers of reinfection cases even after large-scale vaccination. Trials have been carried …

Deuremidevir hydrobromide tablets and simnotrelvir tablets/ritonavir tablets (co-packaged)
were approved by the Chinese National Medical Products Administration for the treatment of …

Introduction: Remdesivir (REM) and monoclonal antibodies (mAbs) could alleviate severe
COVID-19 in at-risk outpatients. However, data on their use in hospitalized patients …

Background: This study aims to investigate the activity of the remdesivir–nirmatrelvir
combination against Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and …

Ursodeoxycholic acid (UDCA) was demonstrated to reduce susceptibility to SARS-CoV-2
infection in vitro and improve infection course in chronic liver diseases. However, real-life …

Background: Nirmatrelvir/ritonavir (NMV/r) and three-day course remdesivir (3RDV) have
been approved as early treatments for COVID-19 outpatients not requiring supplemental …

The Coronavirus Diseases 2019 (COVID-19) has been rapidly spreading globally and has
caused severe harm to the health of people and a substantial social burden. In response to …

The appearance of several coronavirus pandemics/epidemics during the last two decades
(SARS-CoV-1 in 2002, MERS-CoV in 2012, and SARS-CoV-2 in 2019) indicates that …